• Disease
  • Polycystic
  • Polycystic Ovary
  • Polycystic Ovary Syndrome
  • Rogerio A Lobo

    Prominent publications by Rogerio A Lobo

    KOL Index score: 17266

    OBJECTIVE: To determine the effects of lower doses of conjugated equine estrogens (CEE) alone or CEE and medroxyprogesterone acetate (MPA) on lipoproteins, carbohydrate metabolism, and coagulation/fibrinolytic factors.

    DESIGN: Randomized, double-blind, placebo-controlled study.

    SETTING: Multicenter substudy of the Women's HOPE trial.

    PATIENT(S): Seven hundred and forty-nine healthy, postmenopausal women.

    INTERVENTION(S): Women were randomized to receive the following doses in milligrams ...

    Also Ranks for: Lower Doses |  coagulation factors |  conjugated equine estrogens |  cee mpa |  lipids lipoproteins
    KOL Index score: 16816

    OBJECTIVE: To assess message expression of adiponectin and leptin in visceral and SC fat in women with polycystic ovary syndrome (PCOS) and in control women.

    DESIGN: Prospective clinical trial.

    SETTING: Academic medical centers in Mexico City, Mexico and New York, New York.

    PATIENT(S): Women with PCOS and control women.

    INTERVENTION(S): Surgical biopsies of visceral (omental) and subcutaneous (SC) adipose tissue, fasting blood samples, and ultrasound measurements of visceral and SC ...

    Also Ranks for: Women Pcos |  leptin adiponectin |  ovary syndrome |  insulin resistance |  visceral fat
    KOL Index score: 15650

    OBJECTIVE: Metabolic syndrome (MBS) is a common disorder and is thought to be extremely prevalent in polycystic ovary syndrome (PCOS). In the USA the prevalence of MBS in PCOS has been reported to be as high as 43-46% using Adult Treatment Panel III (ATP-III) criteria. Because of differences in diet, lifestyle and genetic factors, we postulated that the prevalence of MBS might not be as high in Italian women. This study sought to determine the prevalence of MBS in Italian women using ...

    Also Ranks for: Mbs Pcos |  metabolic syndrome |  italian women |  criteria prevalence |  polycystic ovary
    KOL Index score: 15644

    BACKGROUND: Live-birth rates after treatment with assisted reproductive technology have traditionally been reported on a per-cycle basis. For women receiving continued treatment, cumulative success rates are a more important measure.

    METHODS: We linked data from cycles of assisted reproductive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for the period from 2004 through 2009 to individual women in order to estimate cumulative ...

    Also Ranks for: Birth Rates |  assisted reproductive technology |  cycle women |  autologous oocytes |  cumulative live
    KOL Index score: 15115

    In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin ...

    Also Ranks for: Hyperandrogenic Women |  cardiovascular risk |  phenotypic variation |  cpcos ovpcos |  iha prevalence
    KOL Index score: 14507

    Polycystic-appearing ovaries (PAO) on ultrasound have been described in a variety of endocrinopathies and also occur in ovulatory women. By some investigators this is merely referred to as 'PCO' (polycystic ovaries). Although there is controversy in this regard, we do not consider women with PAO/PCO who have no known endocrine disturbance to have polycystic ovary syndrome (PCOS) and therefore prefer not to use the term 'PCO' which is often equated with PCOS. We studied 15 ovulatory women ...

    Also Ranks for: Ovulatory Women |  polycystic ovaries |  ovarian morphology |  hormone humans |  normal weight
    KOL Index score: 14489

    BACKGROUND: Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. The ancillary Cognitive and Affective Study (KEEPS-Cog) of the Kronos Early Estrogen Prevention Study (KEEPS) examined the effects of up to 4 y of MHT on cognition and mood in recently postmenopausal women.


    Also Ranks for: Data Women |  hormone therapy |  mht cognition |  cognitive outcomes |  estradiol estrogen
    KOL Index score: 14338

    OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD.

    PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations.

    EVIDENCE: Only studies comparing PCOS with control patients were ...

    Also Ranks for: Cardiovascular Disease |  polycystic ovary syndrome |  androgen excess |  pcos cvd |  consensus statement
    KOL Index score: 14263

    BACKGROUND: Postmenopausal hormone therapy has been examined extensively in relation to cardiovascular disease. However, research relating serum levels of sex hormones to cardiovascular disease is sparse, and the results are inconclusive.

    METHODS: We measured sex hormones in longitudinally collected samples of 180 postmenopausal women, 91 randomized to 17beta-estradiol and 89 to placebo, in the Estrogen in the Prevention of Atherosclerosis Trial. Repeated measures of sex hormone levels ...

    Also Ranks for: Sex Hormones |  serum levels |  postmenopausal women |  subclinical atherosclerosis |  cimt progression
    KOL Index score: 13837

    OBJECTIVE: In some women, a decline in sexual interest accompanies a relative androgen insufficiency after menopause. We sought to characterize the hormonal effects of the combination of oral esterified estrogens and methyltestosterone and to investigate whether this regimen improves hypoactive sexual desire.

    DESIGN: Double-blind randomized trial.

    SETTING: Healthy volunteers in a multicenter research environment.

    PATIENT(S): Postmenopausal women taking estrogen therapy who were ...

    Also Ranks for: Esterified Estrogens |  sexual desire |  postmenopausal women |  estrogen therapy |  outcome measures
    KOL Index score: 13383

    Twenty-three women with polycystic ovary syndrome, 10 women with hypothalamic-pituitary dysfunction, and 50 control subjects were studied in an attempt to investigate the prevalence of psychological stress and its possible relationship to various hormonal parameters. Norepinephrine (NE) excretion, as reflected by urinary 3-methoxy-4-hydroxyphenylglycol (MHPG), and urinary 3-methoxy-4-hydroxymandelic acid (VMA), platelet serotonin, plasma adrenocorticotrophic hormone (ACTH), urinary free ...

    Also Ranks for: Psychological Stress |  polycystic ovary |  mhpg vma |  elevated levels |  adrenal androgens
    KOL Index score: 13185

    OBJECTIVE: To evaluate efficacy, endometrial safety, and overall safety of a single-capsule 17β-estradiol-progesterone (TX-001HR) for treating menopausal moderate-to-severe vasomotor symptoms.

    METHODS: REPLENISH was a phase 3, 12-month, randomized, double-blind, placebo-controlled, multicenter trial. Women (aged 40-65 years) with vasomotor symptoms and a uterus were randomized to daily estradiol (mg)-progesterone (mg) (1/100, 0.5/100, 0.5/50, or 0.25/50), and women in the vasomotor ...

    Also Ranks for: Vasomotor Symptoms |  postmenopausal women |  oral capsule |  estradiol progesterone |  endometrial hyperplasia
    KOL Index score: 13184

    OBJECTIVE: Metabolic syndrome (MBS) is a significant health care problem in postmenopausal women and is driven largely by obesity. We wished to assess the prevalence of insulin resistance (IR), diagnosed using practical methods, and whether several adipocyte factors (adiponectin, leptin, resistin) or the gastric peptide ghrelin, associated with cardiovascular risk, might be abnormal and may relate to IR.

    STUDY DESIGN: We evaluated 37 obese postmenopausal women with MBS and 34 matched ...

    Also Ranks for: Insulin Resistance |  postmenopausal women |  metabolic syndrome |  leptin resistin |  cardiovascular risk


    Rogerio A Lobo: Influence Statistics

    Sample of concepts for which Rogerio A Lobo is among the top experts in the world.
    Concept World rank
    ovulatory cycles aging #1
    polycystic appearing #1
    preembryo donation woman #1
    metabolic parameters safety #1
    chapter 38 primary #1
    lh follicular fluid #1
    low doses cpa #1
    anovulatory pcos p01 #1
    pregnancies highfsh #1
    acth cah patients #1
    syndrome prolactin #1
    scanning mifepristone models #1
    calcitonin human sperm #1
    hd 17519 #1
    gnrh agonist doses #1
    humans testicular hormones #1
    15 women pcos #1
    3 androstenedione #1
    prl pco #1
    75th annual meeting #1
    prevalence mbs #1
    hormone polycystic #1
    women higher ratios #1
    lipoproteins conjugated #1
    manifestation androgen excess #1
    conjugates androsterone glucuronide #1
    quicki total testosterone #1
    quicki lean mass #1
    women ov #1
    te2 preferable treatment #1
    clomiphene dexamethasone #1
    metabolic syndrome mbs #1
    pco hirsutism humans #1
    conventional radioimmunoassay ria #1
    on− postmenopausal women #1
    sicily lower prevalence #1
    peak serum pg #1
    fsh levels cycle #1
    progestogens time #1
    pco prolactin adult #1
    patch pellet #1
    normal women pao #1
    pg retrieved oocyte #1
    hair shaft diameters #1
    pcos ovarian responses #1
    unbound serum pco #1
    prorenin pcos #1
    woman ovarian failure #1
    p01 ovulatory pcos #1
    pco hormone gonadotropins #1

    Key People For Polycystic Ovary Syndrome

    Top KOLs in the world
    Richard S Legro
    polycystic ovary syndrome insulin resistance women pcos
    Ricardo Azziz
    polycystic ovary syndrome women pcos insulin resistance
    Andrea Elizabeth Dunaif
    polycystic ovary syndrome insulin resistance women pcos
    Robert John Norman
    polycystic ovary syndrome weight loss women pcos
    Stephen FRANKS
    polycystic ovary syndrome granulosa cells women pcos
    Evanthia Diamanti‐Kandarakis
    polycystic ovary syndrome insulin resistance women pcos

    Rogerio A Lobo:Expert Impact

    Concepts for whichRogerio A Lobohas direct influence:Polycystic ovary syndrome,  Postmenopausal women,  Ovary syndrome,  Polycystic ovary,  Oocyte donation,  Insulin resistance,  Vitro fertilization,  Hormone therapy.

    Rogerio A Lobo:KOL impact

    Concepts related to the work of other authors for whichfor which Rogerio A Lobo has influence:Polycystic ovary syndrome,  Postmenopausal women,  Insulin resistance,  Breast cancer,  Hormone therapy,  Cardiovascular disease,  Vitro fertilization.



    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, USA. | Department of Obstetrics and Gynecology, Columbia University, United States. | Department of Obstetrics and Gynecology, Columbia Univers